Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Novozymes A/S - SIC # 4959 - SANITARY SERVICES, NOT ELSEWHERE CLASSIFIED
Ticker
Exchange
SIC #
Website
Latest Ticker
NVZMY
Over the counter
4959
www.novonesis.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Novozymes A/S
A Look At Novozymes (CPSE:NSIS B) Valuation After Recent Share Price Weakness
- May 13th, 2026 6:29 pm
Corbion General Shareholders Meeting approves Supervisory Board appointments and dividend
- May 13th, 2026 8:12 am
Novonesis delivered strong start to the year with 7% organic sales growth in Q1
- May 5th, 2026 12:18 am
Interim report Q1 2026
- May 4th, 2026 11:58 pm
FUL vs. NVZMY: Which Stock Should Value Investors Buy Now?
- Apr 16th, 2026 9:40 am
Novozymes Dividend Increase And Valuation Discount Catch Investor Attention
- Apr 4th, 2026 8:07 am
FUL or NVZMY: Which Is the Better Value Stock Right Now?
- Mar 31st, 2026 9:40 am
Resolutions from the Annual General Meeting 2026
- Mar 23rd, 2026 10:54 am
Novonesis issues EUR 1.7 billion in bonds to refinance bridge facility
- Mar 16th, 2026 6:14 am
Novonesis issues EUR 1.7 billion senior unsecured notes
- Mar 13th, 2026 2:56 am
Novozymes Balances Tighter Meeting Access With Higher Dividend Payout Ratio
- Mar 10th, 2026 2:15 am
Novonesis named a Great Employer to Work For in North Carolina
- Mar 9th, 2026 3:32 pm
Invitation to the 2026 Annual General Meeting
- Feb 26th, 2026 4:00 am
Novonesis delivered strong organic sales growth of 7% in 2025
- Feb 25th, 2026 12:11 am
Novonesis' Annual Report 2025
- Feb 24th, 2026 11:57 pm
Is Novozymes (CPSE:NSIS B) Pricing Reflect Recent Valuation Concerns Accurately
- Feb 15th, 2026 10:05 pm
Synthetic Biology and Bioprocessing Market Reaches Multi-Billion Scale with High-Throughput Fermentation and Engineered Microbes Driving Innovation
- Feb 9th, 2026 8:30 am
Cabot Expands Mexico Footprint With MXCB Facility Buyout
- Feb 5th, 2026 7:21 am
CENX's Hawesville Site Sale to Facilitate AI Data Campus Buildout
- Feb 4th, 2026 5:40 am
NVZMY vs. HWKN: Which Stock Is the Better Value Option?
- Feb 3rd, 2026 9:40 am
Scroll